Neuroscience
Parkinson's Disease
100%
Alzheimer's Disease
72%
Multiple Sclerosis
41%
T Cell
22%
Mild Cognitive Impairment
22%
L-DOPA
21%
Experimental Autoimmune Encephalomyelitis
21%
Cognitive Disorders
21%
Blood Brain Barrier
20%
Neurotrauma
19%
Traumatic Brain Injury
19%
Cognitive Function
17%
Central Nervous System
15%
Freezing Of Gait
15%
Brain Ischemia
15%
Magnetic Resonance Imaging
15%
Placebo
13%
Postural Control
12%
Amyloid
12%
Parkinsonism
11%
Behavior (Neuroscience)
10%
Neurodegenerative Disorder
10%
Magnetic Resonance Imaging
10%
Axon
10%
Eicosanoid Receptor
8%
Electrical Brain Stimulation
8%
Neurodegeneration
8%
Brain Tumor
8%
Randomized Controlled Trial
7%
In Vitro
7%
Longitudinal Study
7%
Myelin Basic Protein
7%
T Lymphocyte Receptor
7%
Gene Expression
7%
Electroencephalography
6%
In Vivo
6%
Apolipoprotein E
6%
Epileptic Absence
5%
Stereotypic Movement Disorder
5%
Dystonia
5%
Myelin
5%
Hippocampus
5%
Epitope
5%
Medicine and Dentistry
Apoplexy
27%
Multiple Sclerosis
24%
Parkinson's Disease
23%
Alzheimer's Disease
22%
Disease
21%
Magnetic Resonance Imaging
15%
Brain Ischemia
13%
Clinical Trial
13%
Blood Brain Barrier
13%
Symptom
12%
Traumatic Brain Injury
12%
Epileptic Seizure
9%
COVID-19
9%
Biological Marker
8%
Neoplasm
8%
Central Nervous System
7%
Mild Cognitive Impairment
7%
Drug Therapy
7%
Revascularization
6%
Neurologic Disease
6%
T Cell
6%
Ferumoxytol
6%
Placebo
6%
Randomized Controlled Trial
6%
Stenting
5%
Primary Central Nervous System Lymphoma
5%
Diagnosis
5%
Experimental Autoimmune Encephalomyelitis
5%
Brain Tumor
5%
Thrombectomy
5%
Neurology
5%
Odds Ratio
5%
Systematic Review
5%
Malignant Neoplasm
5%
Cognitive Defect
5%
Keyphrases
Parkinson's Disease
44%
Multiple Sclerosis
27%
Alzheimer's Disease
25%
Experimental Autoimmune Encephalomyelitis
24%
T Cells
13%
Levodopa
10%
Myelin Basic Protein
9%
Central Nervous System
9%
Blood-brain Barrier
9%
Dementia
9%
Blood-brain Barrier Disruption
8%
Cerebrospinal Fluid
8%
Mild Cognitive Impairment
8%
Older Adults
7%
Primary Central Nervous System Lymphoma (PCNSL)
7%
Cognitive Impairment
6%
Cognitive Function
6%
Placebo
6%
Specific T Cells
6%
Clinical Trials
6%
Aging
6%
Lewis Rats
5%
Basic Proteins
5%
T Cell Receptor
5%
Cognitive Decline
5%
Parkinson Patients
5%
Neurodegenerative Diseases
5%
Acute Ischemic Stroke
5%